Akin to the findings in the scenario of AKI, the activity of GSK3β in renal TECs is likewise augmented, marked by GSK3β overexpression, in diverse CKDs, such as diabetic nephropathy18, chronic allograft nephropathy15,32, and, in this study, FSGS and FA nephropathy. This evidence concerns the gene GSK3B and acute kidney injury.